As of late 2019, there have been concerns over a risk of cancer that’s associated with the popular heartburn medication Zantac (ranitidine). Like many of the cancers associated with Zantac, you could be at risk of developing respiratory tract cancer if you’ve ever taken Zantac regularly.
Since the fall of 2019, there have been voluntary recalls of Zantac and other ranitidine products issued by pharmaceutical companies like Sanofi and Denton Pharma. Zantac has been recalled and pulled from the shelves of pharmacies like Walgreens because of detected levels of a possible human carcinogen, or a potentially cancerous chemical.
NDMA And The Link Between Zantac And Cancer
N-nitrosodimethylamine (NDMA) is the probable cancer-causing chemical that was detected in raninitide products in 2019. As determined by the FDA, a human’s daily intake of the chemical NDMA should not exceed 96 nanograms, which breaks down into one billionth of a gram.
There is a concern with Zantac because Valisure, the online pharmacy that discovered NDMA in Zantac OTC after testing individual tablets, found over 2,500,000 nanograms of NDMA in one tablet alone.
The FDA is investigating NDMA levels in ranitidine. Researchers are concerned that, if swallowed, Zantac may somehow convert into NDMA once it enters the body. This could put people at risk of cancer because NDMA has been linked to several different cancers in animal studies.
Cancers Associated With NDMA
Since the discovery of NDMA in ranitidine products, Zantac has been associated with a variety of primary cancer types.
An exposure to NDMA has been linked to:
- lung cancer
- colorectal cancer
- tongue cancer
- kidney cancer
- liver cancer
- stomach cancer
- bladder cancer
- esophagus cancer
- breast cancer
Although the link between NDMA and cancer has been known for years, the recent discovery of the chemical in Zantac is concerning because of the immense popularity of the medication. Ranitidine has been prescribed for millions of people, and the drug was manufactured and sold by numerous pharmaceutical companies who profited from the product.
Is Respiratory Tract Cancer Linked To NDMA?
The U.S. Environmental Protection Agency (EPA) reports that exposure to NDMA in lab rats and mice has caused tumors of the liver, kidney, blood vessels, and the respiratory tract.
Although there has been no direct evidence of NDMA causing respiratory tract cancer in humans, animal studies suggest various cancers are likely to occur in humans exposed to NDMA.
Our Featured Case Results
Types Of Respiratory Tract Cancer
The respiratory tract, which may also be called the respiratory system, includes any organs involved in the process of breathing. If you’re worried about Zantac causing respiratory tract cancer, symptoms will vary depending on the location of the cancer.
Respiratory tract cancer can involve cancer in the:
- trachea (windpipe)
- larynx (voice box)
- bronchus (airway that leads from the trachea to a lung)
Zantac And Lung Cancer
Because of NDMA, Zantac is linked to lung cancer. Lung cancer can develop for various reasons, including smoking and the exposure to certain chemicals.
If you experience any symptoms associated with lung cancer, please consult your physician immediately:
- a new cough that doesn’t go away
- coughing up blood
- shortness of breath
- hoarse voice
- chest pain
Zantac And Cancer Of The Trachea
Cancer of the trachea is considered a respiratory cancer. Because of NDMA, taking Zantac may increase your risk of developing this cancer. The trachea, which is commonly known as the windpipe, is a tube that runs from the larynx to behind the breastbone.
Cancer of the trachea symptoms include:
- dry cough
- trouble swallowing
Zantac And Cancer Of The Larynx
Cancer of the larynx has been associated with NDMA. Although this cancer can also develop for multiple reasons, you may want to keep an eye out for symptoms if you took Zantac frequently.
Symptoms of cancer of the larynx include:
- changes in voice
- feeling of a lump in the throat
- sore throat
Zantac And Cancer Of The Bronchus
A bronchus is an airway or passage that brings air into the lungs. It branches from the trachea. Cancer of the bronchus can stem from health issues associated with the respiratory system. Zantac is associated with cancer of the bronchus because of the chemical NDMA.
Symptoms of bronchus cancer include:
- chest pain
- coughing blood
What To Do If You Have Respiratory Tract Cancer And Have Taken Zantac
After consulting with a doctor, know that you may have options for legal recourse if you have cancer and have taken Zantac. There are currently more than 140 people who have filed Zantac lawsuits against various manufacturers of ranitidine.
You may qualify for a Zantac lawsuit if:
- you took Zantac or another ranitidine product for one year or longer
- you took Zantac at least twice a week for more than a year
- you were diagnosed with respiratory tract cancer or another cancer
We Are Nationally Awarded Lawyers
Contact Florin|Roebig To File A Zantac Lawsuit Today
If you suspect you developed a form of respiratory tract cancer as a result of taking Zantac, you may be eligible to file a lawsuit. Several Zantac lawsuits are already being consolidated into multidistrict litigation suits in Florida. If you think you may have a case, we offer free case evaluations to help you decide if you should file a legal claim.
Our team of qualified dangerous drug attorneys will examine your claim and determine the merits of your case. To start your free case evaluation, or for more information on Zantac lawsuits, contact Florin|Roebig today.